11/12/2024
1:30 PM | Editas Medicine (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
10:57 AM | Editas Medicine (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
6:36 AM | Editas Medicine (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
6:33 AM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
6:04 AM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
12:10 PM | Editas Medicine (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
09/06/2024
3:18 PM | Editas Medicine (Issuer)
O'Neill Gilmore Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
09/06/2024
3:20 PM | Editas Medicine (Issuer)
Mei Baisong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
6:06 AM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
4:02 PM | Burkly Linda (Reporting)
Editas Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
4:01 PM | Editas Medicine (Issuer)
Mei Baisong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
6:23 PM | Editas Medicine (Subject)
Mei Baisong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2024
3:17 PM | Burkly Linda (Reporting)
Editas Medicine (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
5:28 AM | Editas Medicine (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
06/27/2024
4:02 PM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
5:04 AM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
4:11 PM | Editas Medicine (Issuer)
Hirsch Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
4:13 PM | Chatterjee Meeta (Reporting)
Editas Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
4:14 PM | Editas Medicine (Issuer)
Hopfield Jessica (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
4:15 PM | Editas Medicine (Issuer)
Scadden David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:30 PM | Editas Medicine (Issuer)
Reeve Emma (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:30 PM | Editas Medicine (Issuer)
Lucera Erick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
3:32 PM | Editas Medicine (Subject)
Lucera Erick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/14/2024
3:17 PM | Editas Medicine (Issuer)
Hopfield Jessica (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
3:21 PM | Editas Medicine (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024
6:08 AM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
3:30 PM | Editas Medicine (Filer)
| Form DEFA14A | |
04/16/2024
3:25 PM | Editas Medicine (Filer)
| Form DEF 14A | |
04/10/2024
8:37 AM | Editas Medicine (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
03/05/2024
6:54 PM | Editas Medicine (Issuer)
Mei Baisong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:00 PM | Editas Medicine (Issuer)
O'Neill Gilmore Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:03 PM | Burkly Linda (Reporting)
Editas Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:06 PM | Editas Medicine (Issuer)
Lucera Erick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:13 PM | Editas Medicine (Filer)
| Form S-3ASR | |
02/28/2024
3:39 PM | Editas Medicine (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2024
6:06 AM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:40 AM | Deep Track Capital, LP (Filed by)
Editas Medicine (Subject)
| Form SC 13G/A | |
01/24/2024
1:27 PM | BlackRock Inc. (Filed by)
Editas Medicine (Subject)
| Form SC 13G/A | |
01/10/2024
8:09 AM | Editas Medicine (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
12/13/2023
8:02 AM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2023
3:23 PM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
When it comes to NVDA… “acceleration cycles” are the key (Ad) Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options…
By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)...
And thanks to many months and late nights working out the kinks of the systems…
They have finally found a way to target these cycles on Nvidia over and over again. Use this link to see Nvidia Unchained right away! |
12/07/2023
3:30 PM | Eaton Bruce (Reporting)
Editas Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
3:10 PM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free EDIT Stock Alerts